Skip to content

Evaluation of the effect of family participatory dignity therapy for patients with hematological malignancies and family caregivers: A randomised controlled trial

Development and evaluation of family participatory dignity therapy for patients with hematological malignancies and family caregivers: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021433
Enrollment
Unknown
Registered
2019-02-21
Start date
2019-04-01
Completion date
Unknown
Last updated
2019-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological malignancies

Interventions

Experimental group:Conventional care and family participatory dignity therapy
Control group:Conventional care

Sponsors

Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The inclusion criteria for patients are as follows: 1. Inpatients diagnosed with hematologic malignancies for more than one month, including chronic or acute leukemia, malignant lymphoma, multiple myeloma, or myelodysplastic syndrome, etc.; 2. Being 18 years of age or older; 3. Having been informed of disease diagnosis and treatment; 4. Having the complete ability to express and understand. The inclusion criteria for family caregivers are as follows: 1. Patients family members or close relatives; 2. Undertaking the primary responsibility for taking care of the patient; 3. Being 18 years of age or older; 4. Having been informed of patient's disease diagnosis and treatment; 5. Having the complete ability to express and understand.

Exclusion criteria

Exclusion criteria: The exclusion criteria for patients are as follows: 1. Having disorder of consciousness, dementia, or mental illness; 2. Having participated in a similar psychological intervention study. The exclusion criteria for family caregivers are as follows: 1. Having disorder of consciousness, dementia, or mental illness; 2. Having participated in a similar psychological intervention study.

Design outcomes

Primary

MeasureTime frame
Quality of life;Hope level;Spiritual well-being;anxiety;depression;

Countries

China

Contacts

Public ContactRong Hu

School of Nursing, Fujian Medical University

hurong1246@126.com+86 13860623495

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 23, 2026